Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

This population-based study shows that shared and pattern-specific blood biomarkers reflect biological vulnerability ...

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...

Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...

The levels of caffeine in your blood could affect the amount of body fat you carry, a factor that in turn could determine ...

What if we could repair fundamental parts of our bodies? Gene therapy promises just that. It's like having a molecular mechanic that can fix or replace faulty genes, potentially curing diseases ...

Find out more about how blood from older donors may speed Alzheimer’s progression and what this means for future therapies.

Noncancerous blood disorders are conditions that affect blood cells, such as red blood cells, white blood cells, and platelets. Blood disorders may cause symptoms and complications, but most are ...

During colder months, when the risk of complications can increase due to changes in blood pressure and vessel constriction, ...

Low levels of albumin, a protein found in blood, are associated with poor clinical outcomes for people with the fungal ...

Because the risk of many conditions increases with age, doctors generally recommend more frequent lab testing as you get ...